Effect of candesartan, a type I angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma

AIMS: Angiotensin II is a putative mediator in bronchial asthma. There have been very few studies investigating the involvement of angiotensin II receptors in bronchial hyper-responsiveness in asthmatic patients. We examined the effect of candesartan cilexetil, a specific angiotensin II type 1 (AT1)...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Myou, Shigeharu, Fujimura, Masaki, Kamio, Yumie, Kita, Toshiyuki, Watanabe, Kazuyoshi, Ishiura, Yoshihisa, Hashimoto, Takuma, Nakao, Shinji
Format: Artigo
Langue:Inglês
Publié: Blackwell Science Inc 2002
Sujets:
Pharmacodynamics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1874492/
https://ncbi.nlm.nih.gov/pubmed/12492610
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires